demonstrated that the high-dose liraglutide therapy was effective in increasing SHBG levels, while low-dose combination therapy resulted also in a decrease in total testosterone despite the minor effect on BMI [63]
2+ /calmodulin (CaM)-dependent protein kinase kinase/CAM-dependent protein kinase IV/Prolactin regulatory element binding (CaMKK/CaMKIV/PREB), increasing apolipoprotein AI (apo AI) mRNA and promoter expression, and increasing apo AI secretion, thereby mediating intracellular cholesterol efflux
doi: 10.1055/s-2007-1003745 173 ThondamSKDaousiCWildingJPHolstJJAmeenGIYangCet al
This timing captures the trough of your drug exposure the lowest circulating drug level of the week which gives a more reliable baseline for metabolic markers like fasting glucose, insulin, and lipids
Jardine MJ, Zhou Z, Mahaffey KW, et al
Retatrutide can help address these issues